Didactic Series

36
ACCREDITATION STATEMENT: University of California, San Diego School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of California, San Diego School of Medicine designates this educational activity for a maximum of one credit per hour AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. 1 Didactic Series Didactic Series Screening for Alcohol and Substance Abuse in HIV-infected Patients Chris Mathews, M.D., MSPH UCSD Owen Clinic Pacific AETC June 12, 2014

description

Didactic Series. Screening for Alcohol and Substance Abuse in HIV-infected Patients Chris Mathews, M.D., MSPH UCSD Owen Clinic Pacific AETC June 12, 2014. Learning Objectives. Review prevalence of substance use and substance use disorders (SUDs) in HIV-infected patients under care - PowerPoint PPT Presentation

Transcript of Didactic Series

Page 1: Didactic Series

ACCREDITATION STATEMENT: University of California, San Diego School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of California, San Diego School of Medicine designates this educational activity for a maximum of one credit per hour AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

1

Didactic SeriesDidactic Series

Screening for Alcohol and Substance Abuse in HIV-infected Patients

Chris Mathews, M.D., MSPH

UCSD Owen Clinic

Pacific AETC

June 12, 2014

Page 2: Didactic Series

2

Learning Objectives

1) Review prevalence of substance use and substance use disorders (SUDs) in HIV-infected patients under care

2) Review impact of active substance use and SUDs on HIV-related health outcomes

3) Summarize the rationale for & limitations of substance abuse screening tools in HIV-infected patients

4) Describe available screening tools, how to get them and how to use them

Page 3: Didactic Series

3

Self-Reported Substance Abuse Prevalence at Owen Clinic Entry (n=1,682)

0.00%

10.00%20.00%

30.00%

40.00%

50.00%60.00%

70.00%

Lifetime

Current

Page 4: Didactic Series

Poll Question 1

• How often you use any self report substance use screening tools on new HIV patients in your practice?− Always− Most of the time− Sometimes− Rarely− Never

4

Page 5: Didactic Series

Poll Question 2

• When should urine drug screening be performed on HIV patients in your practice? (select as many as apply)− Routinely on all new patients− Routinely on all patients prescribed opiates− Only when abuse or diversion is suspected− As part of a work-up for altered mental status

5

Page 6: Didactic Series

Consequences of Unrecognized and Untreated Substance Use Disorders

(SUDs) for HIV Care• Poorer engagement in care• Less likely to be prescribed antiretroviral therapy• Worse adherence• More likely to be treated at advanced stages of

HIV disease• More rapid disease progression• More likely to have worse treatment outcomes• Risk behavior disinhibition

Chitsaz et al. AIDS Behav (2013) 17:S118–S1276

Page 7: Didactic Series

Conceptual Model of HIV-related Health Behaviors

Chitsaz et al. AIDS Behav (2013) 17:S118–S127 7

Page 8: Didactic Series

Consequences of Unrecognized and Untreated Substance Use Disorders

(SUDs) for HIV Care

Chitsaz et al. AIDS Behav (2013) 17:S118–S127 8

Page 9: Didactic Series

Consequences of Unrecognized and Untreated Substance Use Disorders

(SUDs) for HIV Care

• Drug use severity was negatively and independently correlated with three outcomes just before incarceration: (1) having an HIV care provider

AOR = 0.28

(2) being prescribed antiretroviral therapy AOR = 0.12

(3) high levels (> 95 %) of antiretroviral medication adherence

AOR = 0.18Chitsaz et al. AIDS Behav (2013) 17:S118–S127

9

Page 10: Didactic Series

Consequences of Recent Substance Use for ART Adherence

Rosen et al. AIDS Behav. 2013 Jan;17(1):142-7 10

Page 11: Didactic Series

Consequences of Recent Substance Use for ART Adherence

(ACTG 362)

Cohn et al. AIDS Care. 2011 Jun;23(6):775-8511

Page 12: Didactic Series

Consequences of Recent Substance Use for Mortality(ACTG 362)

Cohn et al. AIDS Care. 2011 Jun;23(6):775-8512

Page 13: Didactic Series

ASAM Definition of Addiction

13

• Addiction is a primary, chronic disease of brain reward, motivation, memory and related circuitry. Dysfunction in these circuits leads to characteristic biological, psychological, social, and spiritual manifestations.

• This revised definition of addiction is characterized by:– Inability to consistently abstain – Impairment in behavioral control – Craving – Diminished recognition of significant problems with one’s

behaviors and interpersonal relationships – A dysfunctional emotional response

http://www.asam.org/research-treatment/definition-of-addiction

Page 14: Didactic Series

Substance Use Disorders and DSM-5

• The term addiction is not applied in DSM-5• The more neutral term of substance use disorder

(SUD)used to describe a wide range of disorder, from mild to severe, chronically relapsing, compulsive drug taking– SUD includes the previous DSM-4 categories of

substance abuse and substance dependence

– 2 defined criteria necessary for SUD diagnosis (DSM-4 required only 1)

• Distinction made between SUD and substance-induced disorders (intoxication and withdrawal)

14

Page 15: Didactic Series

The Screening Process

• Is defined as a range of evaluation procedures and techniques

• Does not enable treatment personnel to make a clinical diagnosis

• Indicates whether a probability exists that the condition sought is present

• Is a preliminary assessment to determine whether key features of a targeted problem are present in an individual.

• Limitations of self-report associated with stigma

SAMHSA TIP 11 15

Page 16: Didactic Series

The Screening Process

• A comprehensive assessment is a thorough evaluation to establish the presence or absence of a disorder or disease.

• Once screening results are known, one of the following three conclusions can be drawn: – The individual is likely to benefit from referral for a

comprehensive assessment.

– Further assessment is unwarranted.

– Screening should be repeated at a later time.

SAMHSA TIP 11 16

Page 17: Didactic Series

Screening tools: Options to Consider

• Single item vs. multi-item

• Alcohol, other substances, or combined

• Self-administered vs. interviewer administered vs. computer-assisted

17

Page 18: Didactic Series

Substance Screening Tools: Examples

Alcohol Screening

• CAGE• MAST• AUDIT• Maximum drinks screener• Frequency of 5+/4+

drinking screener

Combined substance screening

• DAST• NIDA-ASSIST• CRAFFT (for

adolescents)• CAGE-AID• Single question screener

for drug abuse

18

Page 19: Didactic Series

SBIRT Recommended Screening Tools: CAGE

Agerwala et al. J Psychoactive Drugs. 2012 Sep-Oct;44(4):307-17

19

Page 20: Didactic Series

SBIRT Recommended Screening Tools: CRAFFT

Agerwala et al. J Psychoactive Drugs. 2012 Sep-Oct;44(4):307-1720

Page 21: Didactic Series

SBIRT Recommended Screening Tools: AUDIT

Agerwala et al. J Psychoactive Drugs. 2012 Sep-Oct;44(4):307-17

21

Page 22: Didactic Series

SBIRT Recommended Screening Tools: ASSIST

Agerwala et al. J Psychoactive Drugs. 2012 Sep-Oct;44(4):307-17

22

Page 23: Didactic Series

SBIRT Recommended Screening Tools: Single Item Tools

Agerwala et al. J Psychoactive Drugs. 2012 Sep-Oct;44(4):307-17

23

Page 24: Didactic Series

Screening Resources• SAMHSA screening tools URL

– http://www.integration.samhsa.gov/clinical-practice/screening-tools#drugs

• SAMHSA SBIRT (Screening, Brief Intervention, Referral, Treatment)– http://beta.samhsa.gov/sbirt

• CRAFFT– http://www.ceasar-boston.org/CRAFFT/

• AUDIT– http://www.integration.samhsa.gov/

AUDIT_screener_for_alcohol.pdf• DAST

– http://www.emcdda.europa.eu/attachements.cfm/att_61480_EN_DAST%202008.pdf

24

Page 25: Didactic Series

Screening Resources

• AUDIT-C– http://www.integration.samhsa.gov/images/res/

tool_auditc.pdf

• CAGE-AID– http://www.integration.samhsa.gov/images/res/

CAGEAID.pdf

• NIDAMED (resources for health professionals)– http://www.drugabuse.gov/nidamed-medical-health-

professionals

• NIDA Drug Screening Tool (online)– http://www.drugabuse.gov/nmassist/

25

Page 26: Didactic Series

NIDA-ASSIST Online

26

http://www.drugabuse.gov/nmassist/

Page 27: Didactic Series

27

Page 28: Didactic Series

28

Page 29: Didactic Series

29

Page 30: Didactic Series

30

Page 31: Didactic Series

31

Page 32: Didactic Series

32

Page 33: Didactic Series

33

Page 34: Didactic Series

34

Page 35: Didactic Series

Poll Question 3

• How likely are you to implement in the next 3 months routine substance abuse screening using a standardized tool on new HIV patients?− Very likely− Somewhat likely− Possible− Unlikely− Very unlikely

35

Page 36: Didactic Series

Poll Question 4

• How likely are you to implement in the next 3 months routine substance abuse screening using a standardized tool on follow-up HIV patients?− Very likely− Somewhat likely− Possible− Unlikely− Very unlikely

36